Resveratrol, an activator of SIRT1, restores erectile function in streptozotocin-induced diabetic rats

Asian Journal of Andrology

Volumn 15, Issue 5, 2013, Pages 646-651

  Yu, Wen ^a   Wan, Zan ^a   Qiu, Xue Feng ^a   Chen, Yun ^a   Dai, Yu Tian ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Apoptosis; Erectile dysfunction; Oxidative stress; Resveratrol

Indexed keywords

MALONALDEHYDE; PROTEIN P53; RESVERATROL; SIRTUIN 1; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; ERECTILE DYSFUNCTION; IMMUNOHISTOCHEMISTRY; INCIDENCE; LONGEVITY; MALE; NONHUMAN; OXIDATIVE STRESS; PENIS ERECTION; RAT; SMOOTH MUSCLE; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; ERECTILE DYSFUNCTION; FORKHEAD TRANSCRIPTION FACTORS; MALE; PENILE ERECTION; PENIS; RATS; SIRTUIN 1; STILBENES; STREPTOZOCIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84883481844     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2013.60     Document Type: Article

References (46)

1. Richardson D, Vinik A. Etiology and treatment of erectile failure in diabetes mellitus. Curr Diab Rep 2002; 2: 501-9
2. Moore CR, Wang R. Pathophysiology and treatment of diabetic erectile dysfunction. Asian J Androl 2006; 8: 675-84
3. Jeremy JY, Jones RA, Koupparis AJ, Hotston M, Persad R et al. Reactive oxygen species and erectile dysfunction: Possible role of NADPH oxidase. Int J Impot Res 2007; 19: 265-80
4. Safarinejad MR. Oral sildenafil in the treatment of erectile dysfunction in diabetic men: A randomized double-blind and placebo-controlled study. J Diabetes Complications 2004; 18: 205-10
5. Vickers MA, Satyanarayana R. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 2002; 14: 466-71
6. Frei B. Efficacy of dietary antioxidants to prevent oxidative damage and inhibit chronic disease. J Nutr 2004; 134: 3196S-8S.
7. Kundu JK, Surh YJ. Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett 2008; 269: 243-61
8. Shankar S, Nall D, Tang SN, Meeker D, Passarini J et al. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS ONE 2011; 6: E16530
9. Timperio AM, D'Alessandro A, Fagioni M, Magro P, Zolla L. Production of the phytoalexins trans-resveratrol and delta-viniferin in two economy-relevant grape cultivars upon infection with Botrytis cinerea in field conditions. Plant Physiol Biochem 2011; 50: 65-71
10. Sharma S, Chopra K, Kulkarni SK. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: Participation of nitric oxide and TNF-Alpha. Phytother Res 2007; 21: 278-83
11. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004; 430: 686-9
12. Qiu X, Lin H, Wang Y, Yu W, Chen Y et al. Intracavernous transplantation of bone marrow-derived mesenchymal stem cells restores erectile function of streptozocininduced diabetic rats. J Sex Med 2011; 8: 427-36
13. Chen Y, Li XX, Lin HC, Qiu XF, Gao J et al. The effects of long-Term administration of tadalafil on STZ-induced diabetic rats with erectile dysfunction via a local antioxidative mechanism. Asian J Androl 2012; 14: 616-20
14. Do GM, Jung UJ, Park HJ, Kwon EY, Jeon SM et al. Resveratrol ameliorates diabetesrelated metabolic changes via activation of AMP-Activated protein kinase and its downstream targets in db/db mice. Mol Nutr Food Res 2012; 56: 1282-91
15. Singh CK, Kumar A, Hitchcock DB, Fan D, Goodwin R et al. Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam. Mol Nutr Food Res 2011; 55: 1186-96
16. Brasnyo P, Molnar GA, Mohas M, Marko L, Laczy B et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 2011; 106: 383-9
17. Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P et al. Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 2012; 67: 1307-12
18. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 2011; 14: 612-22
19. Jing YH, Chen KH, Kuo PC, Pao CC, Chen JK. Neurodegeneration in streptozotocininduced diabetic rats is attenuated by treatment with resveratrol. Neuroendocrinology; e-pub ahead of print 9 March 2013. Doi: 10.1159/000350435
20. Soufi FG, Mohammad-Nejad D, Ahmadieh H. Resveratrol improves diabetic retinopathy possibly through oxidative stress-nuclear factor kappaB-Apoptosis pathway. Pharmacol Rep 2011; 64: 1505-14
21. Fukuhara S, Tsujimura A, Okuda H, Yamamoto K, Takao T et al. Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: Preliminary findings. J Sex Med 2011; 8: 1061-71
22. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007; 450: 712-6
23. Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 2009; 297: H1876-81
24. Lee JH, Song MY, Song EK, Kim EK, Moon WS et al. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factorkappaB signaling pathway. Diabetes 2009; 58: 344-51
25. Ota H, Akishita M, Eto M, Iijima K, Kaneki M et al. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 2007; 43: 571-9
26. Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 2007; 21: 2644-58
27. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA et al. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 2002; 21: 2383-96
28. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA et al. hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149-59
29. Tang Y, Xu J, Qu W, Peng X, Xin P et al. Resveratrol reduces vascular cell senescence through attenuation of oxidative stress by SIRT1/NADPH oxidase-dependent mechanisms. J Nutr Biochem 2012; 23: 1410-6
30. Kairisalo M, Bonomo A, Hyrskyluoto A, Mudo G, BelluardoN et al. Resveratrol reduces oxidative stress and cell death and increases mitochondrial antioxidants and XIAP in PC6.3-cells. Neurosci Lett 2011; 488: 263-6
31. Akar F, Pektas MB, Tufan C, Soylemez S, Sepici A et al. Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits. Cardiovasc Drugs Ther 2011; 25: 119-31
32. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 2007; 104: 14855-60
33. Vousden KH, Prives C. Blinded by the light: The growing complexity of p53. Cell 2009; 137: 413-31
34. Luo J, Nikolaev AY, Imai S, Chen D, Su F et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001; 107: 137-48
35. Luo J, Su F, Chen D, Shiloh A, Gu W. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 2000; 408: 377-81
36. Tang TT, Dowbenko D, Jackson A, Toney L, Lewin DA et al. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J Biol Chem 2002; 277: 14255-65
37. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M et al. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 2000; 20: 8969-82
38. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002; 419: 316-21
39. Motta MC, Divecha N, Lemieux M, Kamel C, ChenDet al. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004; 116: 551-63
40. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011-5
41. Tarhan F, Demirel GY, Kuyumcuoglu U, Faydaci G, Eryildirim B. Apoptosis of corpus cavernosum in patients with organic erectile dysfunction. World J Urol 2009; 27: 235-40
42. Li XX, Qiu XF, Yu W, Zhu WD, Chen Y et al. Mechanisms of oxidative stress-induced damage and its protection in cavernous mitochondria of diabetic rats. Beijing Da Xue Xue Bao; 43: 189-93. Chinese
43. Trent JT, Falabella A, Eaglstein WH, Kirsner RS. Venous ulcers: Pathophysiology and treatment options. Ostomy Wound Manage 2005; 51: 38-54; quiz 5-6
44. Bordone L, Cohen D, Robinson A, Motta MC, van Veen E et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 2007; 6: 759-67
45. Boily G, Seifert EL, Bevilacqua L, He XH, Sabourin G et al. SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS ONE 2008; 3: E1759
46. Gustaviani R, Soewondo P, Semiardji G, Sudoyo AW. The influence of calorie restriction during the Ramadan fast on serum fructosamine and the formation of beta hydroxybutirate in type 2 diabetes mellitus patients. Acta Med Indones 2004; 36: 136-41